Literature DB >> 8240474

Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities.

W H Giles1, R F Anda, D H Jones, M K Serdula, R K Merritt, F DeStefano.   

Abstract

OBJECTIVE: To investigate recent trends in the percentage and characteristics of patients being treated by a physician for high blood cholesterol (HBC) and to assess missed clinical opportunities to screen for HBC. DESIGN, SETTING, PARTICIPANTS: Telephone interviews of 154,735 adults in 37 states that participated in the Behavioral Risk Factor Surveillance System during 1988-1990 to assess trends in the percentage of patients treated for HBC by a physician. An opportunity was considered missed if a person did not report being screened for HBC despite seeing a physician for preventive care in the last 2 years.
RESULTS: Between the first quarter of 1988 and the last quarter of 1990, the percentage of persons treated by a physician for HBC increased from 7.6% to 11.7% (P < .001). However, since an estimated 36% of US adults need treatment for HBC, fewer than one third of persons who need treatment are receiving it. Persons with two or more cardiac risk factors were more likely to be treated, while men, blacks, persons in lower socioeconomic groups, and persons between 20 and 34 years of age were less likely to be treated. Among the 126,571 persons who had seen a physician for preventive care within the last 2 years, missed opportunities to screen for HBC were most common among persons aged 20 through 34 years (59%) and among women who had seen obstetricians/gynecologists for preventive care (43%).
CONCLUSIONS: Fewer than one third of persons who need treatment for HBC as estimated by data from the second National Health and Nutrition and Nutrition Examination Survey are receiving treatment. Better use of clinical opportunities to screen for HBC could substantially accelerate the progress in identifying persons, young adults in particular, who are likely to benefit from cholesterol reduction.

Entities:  

Mesh:

Year:  1993        PMID: 8240474

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Equity in prevention and health care.

Authors:  V Lorant; B Boland; P Humblet; D Deliège
Journal:  J Epidemiol Community Health       Date:  2002-07       Impact factor: 3.710

2.  Physician extenders for cost-effective management of hypercholesterolemia.

Authors:  G Schectman; N Wolff; J C Byrd; J G Hiatt; A Hartz
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

3.  Undertreatment of hypercholesterolaemia: a population-based study.

Authors:  A K Mantel-Teeuwisse; W M M Verschuren; O H Klungel; D Kromhout; A D Lindemans; J Avorn; A J Porsius; A de Boer
Journal:  Br J Clin Pharmacol       Date:  2003-04       Impact factor: 4.335

4.  Statistical problems.

Authors:  G Davey Smith; M Egger
Journal:  BMJ       Date:  1994-04-16

5.  The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.

Authors:  M J Koren; D G Smith; D B Hunninghake; M H Davidson; J M McKenney; S R Weiss; H G Schrott; R W Henley; P Tresh; R W McLain; R G Bakker-Arkema; D M Black
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 6.  The importance of lowering cholesterol in patients with coronary heart disease.

Authors:  D Eisenberg
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

7.  Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.

Authors:  Ann Hiott Barham; David C Goff; Haiying Chen; Aarthi Balasubramanyam; Erica Rosenberger; Denise E Bonds; Alain G Bertoni
Journal:  Prev Cardiol       Date:  2009

8.  The costs and effects of a nutritional education program following work-site cholesterol screening.

Authors:  T Byers; R Mullis; J Anderson; L Dusenbury; R Gorsky; C Kimber; K Krueger; S Kuester; A Mokdad; G Perry
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

9.  Lipid screening in a managed care population.

Authors:  K C Davis; M E Cogswell; S L Rothenberg; J P Koplan
Journal:  Public Health Rep       Date:  1998 Jul-Aug       Impact factor: 2.792

Review 10.  Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.

Authors:  Catherine Kim; Timothy P Hofer; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.